Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04212117 · ClinicalTrials.gov registry record · NA

CALS Patient Activated Learning System (PALS)

A NA study of Communication and Health Knowledge, Attitudes, Practice, sponsored by Cornell University.

Completed
Registry status
NA
Development phase
232
Enrollment target
1
Study location

NCT04212117 is a NA study of Communication and Health Knowledge, Attitudes, Practice that has completed, run by Cornell University. The registered enrollment target is 232 participants, below the 1,414-participant average among 34 other Communication trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04212117, a NA study of Communication and Health Knowledge, Attitudes, Practice, has completed, sponsored by Cornell University.

COMPLETED
Registry status
NA
Development phase
232 participants
Enrollment target
1
Study location

Study Summary

The overall goal in this line of inquiry is to test whether the Patient Activated Learning System (PALS) is effective in reducing disparities in access to reliable, easily understood health information, and whether this increased understanding has downstream consequences such as increases in trust in the medical system and self-management behaviors.

Interventions

  • OTHER WebMD
  • OTHER The Patient Activated Learning System (PALS)

Study Locations (1)

New York

  • Weill Cornell Medicine - New York

Trial Details

FieldValue
Enrollment Target 232 participants
Start Date 2020-02-18
Est. Completion 2023-11-01
Phase NA

Sponsor

Cornell University

66 total trials

What the Registry Record Tells You About NCT04212117

The ClinicalTrials.gov registry entry for NCT04212117 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 232 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,414-participant average among 34 other Communication trials with a reported enrollment target (84% lower). The listed sponsor is Cornell University, which has 66 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Communication appearing as the primary indexed condition, and to 2 interventions - of which WebMD is the first listed.

NCT04212117 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04212117 about?

NCT04212117 is a clinical study titled "CALS Patient Activated Learning System (PALS)". The overall goal in this line of inquiry is to test whether the Patient Activated Learning System (PALS) is effective in reducing disparities in access to reliable, easily understood health information, and whether this increased understanding has downstream consequences such as increases in trust i...

What is the current status of trial NCT04212117?

This trial is currently completed. It is a NA study. The enrollment target is 232 participants. The study started on 2020-02-18. Estimated completion is 2023-11-01.

What conditions does trial NCT04212117 study?

This clinical trial studies the following conditions: Communication, Health Knowledge, Attitudes, Practice, Trust.

What interventions are being tested in trial NCT04212117?

The interventions under investigation include: WebMD (OTHER), The Patient Activated Learning System (PALS) (OTHER).

Who is sponsoring clinical trial NCT04212117?

This trial is sponsored by Cornell University, which has 66 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04212117 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Communication

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.